Our preliminary data suggest that HCCS expression is significantly elevated in TP53‐mutated breast cancers, raising the possibility of a functional link between p53 dysregulation and mitochondrial pathway activation involving HCCS (Figure 3k). The gene discussed is TP53; the disease is breast cancer.